These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 20882401)

  • 1. Increased levels of anxiety-related behaviors in a Tsc2 dominant negative transgenic mouse model of tuberous sclerosis.
    Ehninger D; Silva AJ
    Behav Genet; 2011 May; 41(3):357-63. PubMed ID: 20882401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
    Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
    Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reversal of learning deficits in a Tsc2+/- mouse model of tuberous sclerosis.
    Ehninger D; Han S; Shilyansky C; Zhou Y; Li W; Kwiatkowski DJ; Ramesh V; Silva AJ
    Nat Med; 2008 Aug; 14(8):843-8. PubMed ID: 18568033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impaired social interactions and motor learning skills in tuberous sclerosis complex model mice expressing a dominant/negative form of tuberin.
    Chévere-Torres I; Maki JM; Santini E; Klann E
    Neurobiol Dis; 2012 Jan; 45(1):156-64. PubMed ID: 21827857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. NitroSynapsin for the treatment of neurological manifestations of tuberous sclerosis complex in a rodent model.
    Okamoto SI; Prikhodko O; Pina-Crespo J; Adame A; McKercher SR; Brill LM; Nakanishi N; Oh CK; Nakamura T; Masliah E; Lipton SA
    Neurobiol Dis; 2019 Jul; 127():390-397. PubMed ID: 30928642
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabotropic glutamate receptor-dependent long-term depression is impaired due to elevated ERK signaling in the ΔRG mouse model of tuberous sclerosis complex.
    Chévere-Torres I; Kaphzan H; Bhattacharya A; Kang A; Maki JM; Gambello MJ; Arbiser JL; Santini E; Klann E
    Neurobiol Dis; 2012 Mar; 45(3):1101-10. PubMed ID: 22198573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex-Selective Effects on Behavior in a Mouse Model of Tuberous Sclerosis Complex.
    Saré RM; Lemons A; Figueroa C; Song A; Levine M; Beebe Smith C
    eNeuro; 2020; 7(2):. PubMed ID: 32303566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TSC-associated neuropsychiatric disorders (TAND): findings from the TOSCA natural history study.
    de Vries PJ; Belousova E; Benedik MP; Carter T; Cottin V; Curatolo P; Dahlin M; D'Amato L; d'Augères GB; Ferreira JC; Feucht M; Fladrowski C; Hertzberg C; Jozwiak S; Kingswood JC; Lawson JA; Macaya A; Marques R; Nabbout R; O'Callaghan F; Qin J; Sander V; Sauter M; Shah S; Takahashi Y; Touraine R; Youroukos S; Zonnenberg B; Jansen AC;
    Orphanet J Rare Dis; 2018 Sep; 13(1):157. PubMed ID: 30201051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of Tsc2 in Purkinje cells is associated with autistic-like behavior in a mouse model of tuberous sclerosis complex.
    Reith RM; McKenna J; Wu H; Hashmi SS; Cho SH; Dash PK; Gambello MJ
    Neurobiol Dis; 2013 Mar; 51():93-103. PubMed ID: 23123587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Everolimus improves neuropsychiatric symptoms in a patient with tuberous sclerosis carrying a novel TSC2 mutation.
    Hwang SK; Lee JH; Yang JE; Lim CS; Lee JA; Lee YS; Lee K; Kaang BK
    Mol Brain; 2016 May; 9(1):56. PubMed ID: 27216612
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors.
    Woodrum C; Nobil A; Dabora SL
    J Transl Med; 2010 Feb; 8():14. PubMed ID: 20146790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinical and genetic study patients with tuberous sclerosis complex].
    Rubilar C; López F; Troncoso M; Barrios A; Herrera L
    Rev Chil Pediatr; 2017 Feb; 88(1):41-49. PubMed ID: 28288225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tuberous sclerosis complex activity is required to control neuronal stress responses in an mTOR-dependent manner.
    Di Nardo A; Kramvis I; Cho N; Sadowski A; Meikle L; Kwiatkowski DJ; Sahin M
    J Neurosci; 2009 May; 29(18):5926-37. PubMed ID: 19420259
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Altered ultrasonic vocalizations in a tuberous sclerosis mouse model of autism.
    Young DM; Schenk AK; Yang SB; Jan YN; Jan LY
    Proc Natl Acad Sci U S A; 2010 Jun; 107(24):11074-9. PubMed ID: 20534473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diagnosis of tuberous sclerosis complex focusing on prenatal period].
    Filipová H; Procházka M; Vrtěl R
    Ceska Gynekol; 2016 Apr; 81(2):147-54. PubMed ID: 27457398
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of 65 tuberous sclerosis complex (TSC) patients by TSC2 DGGE, TSC1/TSC2 MLPA, and TSC1 long-range PCR sequencing, and report of 28 novel mutations.
    Rendtorff ND; Bjerregaard B; Frödin M; Kjaergaard S; Hove H; Skovby F; Brøndum-Nielsen K; Schwartz M;
    Hum Mutat; 2005 Oct; 26(4):374-83. PubMed ID: 16114042
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tuberous Sclerosis Complex in Chinese patients: Phenotypic analysis and mutational screening of TSC1/TSC2 genes.
    Lin S; Zeng JB; Zhao GX; Yang ZZ; Huang HP; Lin MT; Wu ZY; Wang N; Chen WJ; Fang L
    Seizure; 2019 Oct; 71():322-327. PubMed ID: 31525612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Deep phenotyping of patients with Tuberous Sclerosis Complex and no mutation identified in TSC1 and TSC2.
    Peron A; Vignoli A; Briola F; Morenghi E; Tansini L; Alfano RM; Bulfamante G; Terraneo S; Ghelma F; Banderali G; Viskochil DH; Carey JC; Canevini MP;
    Eur J Med Genet; 2018 Jul; 61(7):403-410. PubMed ID: 29432982
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A Farnesyltransferase Inhibitor Restores Cognitive Deficits in
    Sugiura H; Shimada T; Moriya-Ito K; Goto JI; Fujiwara H; Ishii R; Shitara H; Taya C; Fujii S; Kobayashi T; Hino O; Worley PF; Yamagata K
    J Neurosci; 2022 Mar; 42(12):2598-2612. PubMed ID: 35121635
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased susceptibility to kainate-induced seizures in a mouse model of tuberous sclerosis complex: Importance of sex and circadian cycle.
    Pais ML; Martins J; Castelo-Branco M; Gonçalves J
    Epilepsia Open; 2024 Oct; 9(5):1710-1722. PubMed ID: 39010669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.